|
Originally published In Press as doi:10.1074/jbc.M506740200 on December 29, 2005
J. Biol. Chem., Vol. 281, Issue 9, 5861-5868, March 3, 2006
Tumor Cells Enhance Their Own CD44 Cleavage and Motility by Generating Hyaluronan Fragments*
Kazuki N. Sugahara ,
Takako Hirata ,
Haruko Hayasaka ,
Robert Stern¶,
Toshiyuki Murai , and
Masayuki Miyasaka 1
From the
Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan, The 21st Century COE Program, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan and the ¶Department of Pathology, School of Medicine, University of California, San Francisco, California 94143
Hyaluronan (HA) is an extracellular matrix glycosaminoglycan that interacts with cell-surface receptors, including CD44. Although HA usually exists as a high molecular mass polymer, HA of a much lower molecular mass that shows a variety of biological activities can be detected under certain pathological conditions, particularly in tumors. We previously reported that low molecular weight HAs (LMW-HAs) of a certain size range induce the proteolytic cleavage of CD44 from the surface of tumor cells and promote tumor cell migration in a CD44-dependent manner. Here, we show that MIA PaCa-2, a human pancreatic carcinoma cell line, secreted hyaluronidases abundantly and generated readily detectable levels of LMW-HAs ranging from 10- to 40-mers. This occurred in the absence of any exogenous stimulation. The tumor-derived HA oligosaccharides were able to enhance CD44 cleavage and tumor cell motility. Inhibition of the CD44-HA interaction resulted in the complete abrogation of these cellular events. These results are consistent with the concept that tumor cells generate HA oligosaccha-rides that bind to tumor cell CD44 through the expression of their own constitutive hyaluronidases. This enhances their own CD44 cleavage and cell motility, which would subsequently promote tumor progression. Such an autocrine/paracrine-like process may represent a novel activation mechanism that would facilitate and promote the malignant potential of tumor cells.
Received for publication, June 21, 2005
, and in revised form, November 17, 2005.
* This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Osaka University Graduate School of Medicine C8, 2-2, Yamada-oka, Suita 565-0871, Japan. Tel.: 81-6-6879-3972; Fax: 81-6-6879-3979; E-mail: mmiyasak{at}orgctl.med.osaka-u.ac.jp.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. N. Sugahara, T. Hirata, T. Tanaka, S. Ogino, M. Takeda, H. Terasawa, I. Shimada, J.-i. Tamura, G. B. ten Dam, T. H. van Kuppevelt, et al.
Chondroitin Sulfate E Fragments Enhance CD44 Cleavage and CD44-Dependent Motility in Tumor Cells
Cancer Res.,
September 1, 2008;
68(17):
7191 - 7199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kaneiwa, S. Yamada, S. Mizumoto, A. M. Montano, S. Mitani, and K. Sugahara
Identification of a Novel Chondroitin Hydrolase in Caenorhabditis elegans
J. Biol. Chem.,
May 30, 2008;
283(22):
14971 - 14979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lerdrup, S. Bruun, M. V. Grandal, K. Roepstorff, M. M. Kristensen, A. M. Hommelgaard, and B. van Deurs
Endocytic Down-Regulation of ErbB2 Is Stimulated by Cleavage of Its C-Terminus
Mol. Biol. Cell,
September 1, 2007;
18(9):
3656 - 3666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Takeda, S. Ogino, R. Umemoto, M. Sakakura, M. Kajiwara, K. N. Sugahara, H. Hayasaka, M. Miyasaka, H. Terasawa, and I. Shimada
Ligand-induced Structural Changes of the CD44 Hyaluronan-binding Domain Revealed by NMR
J. Biol. Chem.,
December 29, 2006;
281(52):
40089 - 40095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Misra, B. P. Toole, and S. Ghatak
Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells
J. Biol. Chem.,
November 17, 2006;
281(46):
34936 - 34941.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|